Analysts Have Made A Financial Statement On thyssenkrupp nucera AG & Co. KGaA’s (ETR:NCH2) Second-Quarter Report

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

Analysts Have Made A Financial Statement On thyssenkrupp nucera AG & Co. KGaA’s (ETR:NCH2) Second-Quarter Report

It’s been a sad week for thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2), who’ve watched their investment drop 12% to €8.73 in the week since the company reported its second-quarter result. Revenues were €216m, with thyssenkrupp nucera KGaA reporting some 2.0% below analyst expectations. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual. With this in mind, we’ve gathered the latest statutory forecasts to see what the analysts are expecting for next year.

This is the hidden content, please

• Sign In
• or
• Sign Up

XTRA:NCH2 Earnings and Revenue Growth May 18th 2025

Following the recent earnings report, the consensus from eleven analysts covering thyssenkrupp nucera KGaA is for revenues of €895.7m in 2025. This implies a discernible 7.6% decline in revenue compared to the last 12 months. Statutory earnings per share are expected to nosedive 62% to €0.072 in the same *******. Yet prior to the latest earnings, the analysts had been anticipated revenues of €890.3m and earnings per share (EPS) of €0.072 in 2025. So it’s pretty clear that, although the analysts have updated their estimates, there’s been no major change in expectations for the business following the latest results.

This is the hidden content, please

• Sign In
• or
• Sign Up

It will come as no surprise then, to learn that the consensus price target is largely unchanged at €12.30. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company’s valuation. There are some variant perceptions on thyssenkrupp nucera KGaA, with the most bullish analyst valuing it at €17.00 and the most bearish at €8.50 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Taking a look at the ******* picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and

This is the hidden content, please

• Sign In
• or
• Sign Up

growth estimates. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 15% by the end of 2025. This indicates a significant reduction from annual growth of 33% over the last year. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 4.0% per year. It’s pretty clear that thyssenkrupp nucera KGaA’s revenues are expected to perform substantially worse than the wider industry.

Story Continues

The most obvious conclusion is that there’s been no major change in the business’ prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year’s earnings. We have forecasts for thyssenkrupp nucera KGaA going out to 2027, and you can

This is the hidden content, please

• Sign In
• or
• Sign Up

Even so, be aware that

This is the hidden content, please

• Sign In
• or
• Sign Up

, you should know about…

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

This is the hidden content, please

• Sign In
• or
• Sign Up

#Analysts #Financial #Statement #thyssenkrupp #nucera #KGaAs #ETRNCH2 #SecondQuarter #Report

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up